wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42869354-1AB61D86-94ED-4003-949A-393AE16AB832
Q42869354-1AB61D86-94ED-4003-949A-393AE16AB832
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42869354-1AB61D86-94ED-4003-949A-393AE16AB832
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
P2860
Q42869354-1AB61D86-94ED-4003-949A-393AE16AB832
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42869354-1AB61D86-94ED-4003-949A-393AE16AB832
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8602f175acb8eba44d4908803c1f366577e361b2
P2860
The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies.